OptionsXpress Stock Falls On Unusually High Volume (OXPS)

NEW YORK ( TheStreet) -- optionsXpress Holdings (NYSE: OXPS) is trading at unusually high volume Monday with 4.4 million shares changing hands. It is currently at 4.2 times its average daily volume and trading down 24 cents (-2%) at $11.72 as of 12:10 p.m. ET.

optionsXpress has a market cap of $724.9 million and is part of the financial sector and financial services industry. Shares are down 19.6% year to date as of the close of trading on Friday.

optionsXpress Holdings, Inc. provides brokerage and education services in the United States and internationally. The company offers Internet-based options, stock, bond, mutual fund, and futures brokerage services to retail customers. The company has a P/E ratio of 15.4, equal to the average financial services industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates optionsXpress as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, notable return on equity and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, feeble growth in the company's earnings per share and deteriorating net income. You can view the full optionsXpress Ratings Report.

See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center.

Interested in other stocks that are falling on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting HVDOWN to 95370 or select from multiple alert options.

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing